Roche has announced plans to launch a new serology test to detect protective antibodies in people who have been exposed to the SARS-CoV-2 virus. The test is expected to be available by early May in countries that recognise the CE registration mark. The company is also applying to the US Food and Drug Administration to get emergency use authorisation for the US market.
